BlackRock Enhanced Large Cap Core (NYSE: CII) director logs 29.24 cash-settled Performance Rights
Rhea-AI Filing Summary
BlackRock Enhanced Large Cap Core Fund, Inc. director reported a new equity-linked compensation accrual. On 01/02/2026, the reporting person acquired 29.24 Performance Rights under the BlackRock Deferred Compensation Plan. Each Performance Right is convertible into the cash value of one share of BlackRock Enhanced Large Cap Core Fund, Inc. and is to be settled 100% in cash at the deferral period chosen by the reporting person.
Following this transaction, the reporting person beneficially owned 3,226.99 derivative securities in the form of Performance Rights, held directly. These instruments track the value of the fund’s common stock but do not represent direct share ownership, since they are settled in cash rather than stock.
Positive
- None.
Negative
- None.
FAQ
What insider transaction was reported for CII on 01/02/2026?
A director of BlackRock Enhanced Large Cap Core Fund, Inc. (CII) reported acquiring 29.24 Performance Rights on 01/02/2026 under a deferred compensation arrangement.
What are the Performance Rights reported by the CII director?
The filing states that one Performance Right is convertible into the cash value of one share of BlackRock Enhanced Large Cap Core Fund, Inc., rather than into actual shares.
How will the CII director’s Performance Rights be settled?
According to the disclosure, the Performance Rights are to be settled 100% in cash at the deferral period chosen by the reporting person.
How many derivative securities does the CII director hold after this transaction?
After the reported transaction, the director beneficially owned 3,226.99 derivative securities in the form of Performance Rights, held directly.
Under which plan were the CII Performance Rights accrued?
The filing explains that the Performance Rights were accrued under the BlackRock Deferred Compensation Plan.
Does this Form 4 for CII involve direct common stock transactions?
The disclosed activity involves Performance Rights, which are derivative, cash-settled instruments tied to the value of CII common stock, not direct purchases or sales of common shares.